Ipilimumab/nivolumabLymphocytic myocarditis

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2003卷 / 1期

关键词：

D O I：

10.1007/s40278-024-56309-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：478 / 478

相关论文

共 50 条

[1] Atezolizumab/ipilimumab/nivolumabLymphocytic colitis : 3 case reports
[J]. Reactions Weekly, 2018, 1700 (1) : 47 - 47
[2] Atezolizumab/ipilimumab/nivolumabLymphocytic colitis: 3 case reports
[J]. Reactions Weekly, 2018, 1699 (1) : 39 - 39
[3] Ipilimumab/nivolumabLymphocytic colitis-like pattern of mucosal injury: case report
[J]. Reactions Weekly, 2019, 1757 (1) : 177 - 177
[4] Ipilimumab and nivolumab: fatal myocarditis
[J]. Reactions Weekly, 2016, 1628 (1) : 7 - 7
[5] Ipilimumab/nivolumabHepatitis and myocarditis: case report
[J]. Reactions Weekly, 2023, 1965 (1) : 257 - 257
[6] Ipilimumab/nivolumabMyositis and myocarditis: case report
[J]. Reactions Weekly, 2020, 1797 (1) : 150 - 150
[7] Ipilimumab/nivolumabImmunotherapy-induced myocarditis
[J]. Reactions Weekly, 2024, 2000 (1) : 200 - 200
[8] Ipilimumab/nivolumabFulminant myocarditis: case report
[J]. Reactions Weekly, 2017, 1682 (1) : 174 - 174
[9] Ipilimumab/nivolumabFatal myocarditis: case report
[J]. Reactions Weekly, 2021, 1885 (1) : 278 - 278
[10] Ipilimumab/nivolumabAutoimmune myocarditis: case report
[J]. Reactions Weekly, 2016, 1611 (1) : 109 - 109

← 1 2 3 4 5 →